Christian Hordo - 30 Aug 2021 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP, Chief Business Officer
Signature
/s/ James J. MacDonald, Attorney-in-Fact for Christian Hordo
Issuer symbol
SANA
Transactions as of
30 Aug 2021
Net transactions value
-$55,905
Form type
4
Filing time
01 Sep 2021, 16:20:35 UTC
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Options Exercise $1,628 +1,100 +0.11% $1.48 976,100 30 Aug 2021 Direct
transaction SANA Common Stock Sale $27,511 -1,100 -0.11% $25.01 975,000 30 Aug 2021 Direct F1, F2
transaction SANA Common Stock Sale $30,022 -1,200 -0.12% $25.02 973,800 30 Aug 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Options Exercise $0 -1,100 -0.8% $0.000000 136,400 30 Aug 2021 Common Stock 1,100 $1.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.000 to $25.025, inclusive.
F4 This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.